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ablation (RFTA) of hepatic tumors. The aim was to compare the use of fentanyl administered
through the patient controlled analgesia (PCA) machine with the same drug given intermittently
by the anesthesiologist.
Methods: In this prospective, randomized, double-blind study, eighty cirrhotic patients underwent
RFTA of hepatic tumors were enrolled. All patient received midazolam 10 lg/kg and fentanyl 1 lg/
kg IV, then 5–10 mL of 2% lidocaine were injected from the skin to the liver capsule along a spec-
iﬁed insertion route, then the RFTA electrode was advanced into the tumor. For maintenance of
analgesia bolus doses of fentanyl were then administered either by patient himself (PCA group,
n= 40) with each bolus dose contained 10 lg of fentanyl with a 1 min lock-out time or by the anes-
thesiologist (ACA group, n= 40).Kanat E1 Suwis Av., Shatby,
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62 M.H. Abdullah et al.Results: PCA group received signiﬁcantly higher doses of fentanyl with a mean value of
53.5 ± 13.5 lg/session, while it was 36.7 ± 13.4 lg/session in the ACA group. Patient satisfaction
rates were higher in the PCA than ACA with mean values of 8.32 ± 0.62 and 7.85 ± 0.73, respec-
tively. The mean pain score was statistically lower in the PCA group than the ACA group with mean
value 3.37 ± 0.70 and 3.97 ± 0.89, respectively. There was signiﬁcant difference in themean values of
the demand/ delivered ratio between groups to be 1.47 ± 0.28 and 2.50 ± 0.73 in PCA and ACA
groups, respectively.
Conclusion: PCA with fentanyl proved to be a better alternative than ACA in terms of patient com-
fort and satisfaction.
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Radiofrequency thermal ablation (RFTA) is a technique in
which an electromagnetic energy deposition is used to ther-
mally ablate the hepatic tumor tissue [1,2]. During RFTA
treatment, heat energy generated by high-frequency alternating
currents targeted at the living tissues causes protein denatur-
ation at a temperature of 60–110 C through ionic vibration,
resulting in coagulative necrosis of the target lesion. In addi-
tion, RFTA treatment stimulates the immune system and pro-
vides an easy way to achieve in vivo vaccination against
tumoral antigens [3]. RFTA is generally indicated for hepato-
cellular carcinoma (HCC) patients who are not candidates for
either liver resection or transplantation [4]. Even with appro-
priate conscious sedation, patients may experience pain during
ablation procedures. Pre-operatively, one of the most common
questions asked by those patients is the amount of pain they
will experience during the procedure [5].
Patient-controlled analgesia (PCA) is commonly assumed
to imply on-demand, intermittent, IV administration of opi-
oids under patient control with or without a continuous back-
ground infusion. This technique is based on the use of a
sophisticated microprocessor-controlled infusion pump that
delivers a preprogrammed dose of opioids when the patient
pushes a demand button.
The aim of this work was to compare the analgesic efﬁcacy
and side effects of patient versus anesthesiologist controlled
analgesia in cirrhotic (child A and B) patients undergoing per-
cutaneous radiofrequency thermal ablation of inoperable he-
patic tumors.
2. Patients and methods
This prospective, randomized, double-blinded study was per-
formed in the National Liver Institute – Menofeya University
from August 2008 to April 2011. Ethical approval for this
study was provided by the Ethical Committee of the anesthesia
department, National Liver Institute – Menofeya university. In
this work, eighty cirrhotic patients (Child A and B) between 55
and 82 years of age were scheduled for sonographically guided
radiofrequency thermal ablation for hepatic tumors. The diag-
nosis of hepatic tumors was conﬁrmed with the use of a sono-
graphically guided percutaneous needle biopsy, imaging
ﬁndings of a newly presenting tumor on follow-up, and a char-
acteristic enhancement pattern on contrast-enhanced multi-
phase helical CT or dynamic contrast-enhanced MRI or
both elevated levels of serum tumor markers (a-fetoprotein le-
vel >200 ng/mL) and radiologic ﬁndings.3. Inclusion and exclusion criteria
The inclusion criteria were including: a single nodular HCC
not greater than 5 cm in maximum diameter; up to three mul-
tinodular HCCs, with each tumor measuring up to 3 cm in
maximum diameter; absence of portal venous thrombosis;
Child-Pugh classiﬁcation A or B liver cirrhosis; a prothrombin
time ratio >50% (prothrombin time with international nor-
malized ratio <1.7); and a platelet count greater than
70,000 cells/mm3. Patients were excluded from the study if they
had any of the following: nodules adjacent to the hepatic hilum
due to the risk of thermal injury of the biliary tract; and nod-
ules adjacent to any part of the gastrointestinal tract, [6] his-
tory of use of analgesic and/or sedative agents in the past
7 days prior to RF sessions; history of alcohol abuse; a lan-
guage barrier or mental disorder that would prevent them
from understanding how to operate a patient controlled anal-
gesia machine; any degree of encephalopathy, or allergy to any
of the study medications.
A list had been created where the numbers from 1 to 80
were randomly assigned to one of the two groups by drawing
lots. The patients were put on the list in order of recruitment.
Patients were randomized to one of two groups; anesthesiol-
ogist-controlled analgesia (group ACA) (n= 40) or patient-
controlled analgesia (group PCA) (n= 40). In ACA group
patients received their analgesia by the same anesthesiologist
throughout the study to eliminate inter-physician variability.
All data were recorded by a qualiﬁed, independent observer
who was blinded to group assignment. Prior to the RFTA
procedure, each patient received appropriately detailed
instructions regarding proper use of a patient-controlled
analgesia device (Master PCA IS – Fesrsenius – France).
Speciﬁcally, patients were asked to ‘‘push the button’’ in
response to pain. The RF ablation was performed under
real-time ultrasound guidance.
For lesions in the right lobe, an intercostal approach with
the patient in the left lateral decubitus position was used, while
for lesions in the left lobe, a subcostal or subxiphoid approach
was used.
All patients were premeditated by ondasetron 4 mg and
after being positioned on the RF table, an electrocardiogram,
a non-invasive blood pressure, and a pulse oximeter were ap-
plied to each patient. Supplemental oxygen at a ﬂow rate of
4 L/min was administered via nasal cannulae. After recording
baseline measurements, all patient received midazolam 10 lg/
kg and fentanyl 1 lg/kg IV. After cleaning the skin with io-
dized alcohol (also used as contact medium), the local anesthe-
sia using 2% lidocaine percutaneously was provided by
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sule along a speciﬁed insertion route, then the RFTA electrode
was advanced into the tumor (Angio-Dynamics Inc- RITA,
model 1500X, USA). For maintenance of analgesia bolus
doses of fentanyl were then administered either by patient him-
self (PCA) group using the PCA delivery system or by the
anesthesiologist (ACA) group.
In the PCA group, a standard patient-controlled analgesia
pump was loaded with a 20 cm syringe containing 200 lg fen-
tanyl in normal saline made per patient with a concentration of
10 lg fentanyl/ml. Each bolus dose contained 10 lg of fentanyl
with a 1 min lock-out time. In the ASA group the anesthesiol-
ogist titrated fentanyl doses according to his perception about
the patient’s comfort while at the same time, patients were gi-
ven the push button of a patient-controlled analgesia machine
that had the same settings as the machine used in group PCA
but the syringe was preﬁlled with normal saline to maintain
blinding. The infusion was terminated at the end of the session.
RF sessions were began 5 min after administration of the fen-
tanyl/midazolam bolus in both study groups. Rescue analgesia
was provided by fentanyl 50 lg IV once, in response to patient
request for additional analgesia; or more than 30% increase in
the Heart rate or arterial pressure.
Before the procedure, we explained the use of the visual
analog scale (VAS) to every single patient. The VAS consists
of a 10-cm line which was anchored at one end by a label
‘‘no pain, score 0’’ and at the other end by a label ‘‘pain as
bad as can be, score 10’’ [7–9].
4. Measurements
Physiological parameters that included: heart rate, systolic and
diastolic blood pressure, respiratory rate and oxygen saturation
were all recorded before the RFTA session and every 5 min
after its onset. Pain was assessed at baseline, and every 5 min
during RFTA using a visual analog scale (VAS) ruler with
two anchor points; 0 being no pain, and 10 being the worst pain
the patient had ever experienced. The VAS score was consid-
ered to be 0 if the patient was asleep at the time of assessment,
which was determined by a lack of response to a gentle call of
the patient’s name by the blinded observer. No attempts were
made to wake up those who were asleep to determine their
VAS score. At the end of procedure, total dose of fentanyl hav-
ing been administered, the ratio between the number of total re-
quests (demand) of self-administration to the number of
successful attempts (delivery) to were recorded [10].
After arrival to the post RFTA observation area, patients
were asked to rate their satisfaction with the analgesic manage-
ment during the overall surgical experience using a 10-point
verbal rating scale. The radiologist, also blinded to group allo-
cation, was asked to the degree of his satisfaction with the pa-
tient’s tolerance of RFTA using the same method. All adverse
events including, but not limited to, respiratory depression (de-
ﬁned as a respiratory rate 610 breaths/min), any episode of
oxygen desaturation (oxygen saturation <92%), the need for
rescue analgesia or even general anesthesia were recorded.
5. Statistical analysis
The statistical power of the matched analysis was computed in
a pilot study performed prior to this study (20 cases in eachgroup). It was observed that the visual analog scale (VAS)
scores changed clinically and signiﬁcantly by 70% in the pilot
study. Based on the estimates, a sample size that would permit
type I error of less than 0.05 and power of 90% was calculated.
Enrollment of 40 patients in each group was found to be
sufﬁcient. Statistical analyses were performed using SPSS
Ver. 17 software (Statistical Package for Social Sciences for
Windows, SPSS Inc., Chicago, IL, USA). The one-way ANO-
VA was applied to normally distributed data. The pain VAS
and satisfaction score were analyzed using a Kruskal–Wallis
test. Changes in blood pressures and heart rates among the
groups were compared using repeated measures of one-way
ANOVA. Parametric summary statistics are presented as
mean ± SD. Non-parametric summary statistics are presented
as median (interquartile range). Subgroup analysis within the
same group was performed with the Pearson chi squared test
or Fisher’s exact test.
6. Results
Eighty consecutive cirrhotic patients Child A–B whom under-
going radiofrequency thermal ablation of hepatic tumors were
recruited into the study. Forty patients were allocated to re-
ceive patient controlled analgesia (PCA) while the other forty
patients received intermittent anesthesiologist-controlled anal-
gesia (ACA). (Table 1) is showing the patient characteristics,
etiology of liver cirrhosis and Child classiﬁcation of the studied
groups. There were no signiﬁcant differences between the two
studied groups in terms of age, weight, etiology of liver cirrho-
sis and history of previous ablations p> 0.05. There were no
signiﬁcant differences between the two groups according to
either tumors characteristics or durations of RFTA procedure,
p> 0.05 (Table 2). Patients used the PCA machine received
signiﬁcantly higher doses of fentanyl with a mean value of
53.5 ± 13.5 lg/session, while it was 36.7 ± 13.4 lg/session in
the ACA group with P< 0.05 (Fig. 1). Post procedure patient
satisfaction rates were higher signiﬁcantly in the PCA than
ACA (Table 3). The mean pain score (VAS) was lower in the
PCA group than the ACA group with difference between the
means reached statistical signiﬁcance with P< 0.05. There
was signiﬁcant differences in the mean values of the demand/
delivered ratio between groups to be 1.47 ± 0.28 and
2.50 ± 0.73 in PCA and ACA groups, respectively (Fig. 2).
7. Discussion
Over the last two decades an increasing number of minimally
invasive, local techniques for ablative therapies have been
evolved, challenging the role of surgical resection [11]. Radio-
frequency ablation (RFTA) in particular, has increasingly been
employed with promising results [12,13]. With the new abla-
tion techniques, all hepatic segments can effectively be treated
by RFTA [14,15].
Radiofrequency ablation is considered to be a painful pro-
cedure, and it attracted a limited interests in the literatures.
Traditionally, the purpose has to render this procedure to be
safe and tolerable rather than pain free. Also, with similar pro-
cedures or during monitored anesthesia care interventions, the
level of analgesia and sedation are modulated at the discretion
of the anesthesiologist point of view, according to the per-
ceived patient requirements. Currently, it has been suggested
Table 1 Patient characteristics, etiology of liver cirrhosis and
Child classiﬁcation of the studied groups.
PCA group (n= 40) ACA group (n= 40)
Age (years) 62.8 ± 6.27 62.3 ± 5.59
Weight (kg) 78.1 ± 4.23 77.7 ± 5.19
Height (cm) 173 ± 5.1 172 ± 5.48
Male/female 31/9 29/11
Etiology of liver cirrhosis
HCV (%) 33 (82.5) 35 (87.5)
HBV (%) 2 (5) 2 (5)
HCV+ HBV (%) 3 (7.5) 2 (5)
Alcoholic (%) 2 (5) 1 (2.5)
Child classiﬁcation
Child A (%) 29 (72.5) 27 (67.5)
Child B (%) 11 (27.5) 13 (32.5)
Previous ablation
Non (%) 31 (77.5) 32 (80)
Yes (%) 9 (22.5) 8 (20)
Co-morbid factors
Cardiovascular (%) 3 (7.5) 4 (10)
Pulmonary (%) 6 (15) 8 (20)
Diabetes (%) 11 (27.5) 9 (22.5)
PCA: patient-controlled analgesia; ACA: anesthesiologist-con-
trolled analgesia, HCV: hepatitis C virus, HBV: hepatitis B virus.
Data presented as mean ± standard deviation or absolute numbers
(percentage). All Data Showed no statistical signiﬁcance
(P> 0.05).
Figure 1 Fentanyl consumption during the radiofrequency
ablation in lg/session in the studied groups.
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has the privilege that it can be adjusted to respond better to
the demands of those critical cirrhotic patients and thus im-
prove the quality of pain control [16]. This randomized, dou-
ble-blind study demonstrated that PCA for RFTA is
associated with better pain control compared with ACA. How-
ever, this was reached at the expense of higher drug consump-
tion and possibility of complications.
Since that fentanyl and midazolam administered intermit-
tently have been the conventional mode of pain relief in RFTA
unit of our institute, we decided to compare the use of fentanyl
administered through the PCA machine with the same drug gi-
ven intermittently by the attending anesthesiologist. However,
we chose to retain the use of midazolam in this study because
of its excellent sedative and anxiolytic effects but only used a
ﬁxed single dose of this drug at the start of the procedure be-Table 2 Tumors characteristics and duration of RFA procedure.
P
Pre-ablation maximal tumors diameter (cm) 4
Intrahepatic tumors location
Peripheral near organs (%) 4
Central (%) 2
Close to major vessels (%) 7
RFA Session duration (min) 1
PCA: patient-controlled analgesia; ACA: anesthesiologist-controlled
mean ± standard deviation, or absolute numbers (percentage). All datacause we believed that excessive amounts of midazolam could
potentially inhibit the patient’s ability to operate the PCA de-
vice. Also it might lead to a bias in the assessment of the mem-
ory of the pain felt during the procedure. The qualities of local
anesthesia were good in all patients of the two groups. There
were no incidences of patients complaints during percutaneous
needle insertion after the local lidocaine inﬁltration.
Pain is considered to be a perception; it is deﬁned as an
unpleasant sensory and emotional experience that may be
associated with actual or potential tissue damage [17]. There
are three major categories of nociceptors––thermal, mechani-
cal, and polymodal. Thermal nociceptors are known to be acti-
vated by extreme temperatures (>45 C or <5 C). Polymodal
nociceptors are triggered by high-intensity mechanical, chemi-
cal, or thermal (both hot and cold) stimuli. The three catego-
ries of nociceptors are widely distributed in the skin and
deep tissues, and nociceptors are believed to work together
[17]. The liver is supplied by hepatic nerves that arise from
the hepatic plexus and contain both sympathetic and parasym-
pathetic ﬁbers. It is widely accepted that the parenchyma of the
liver is insensitive to pain [18,19]. However, pain during the
ablation procedures can develop in spite of appropriate con-
scious sedation techniques [20]. It has been demonstrated that
radiofrequency ablation of a tumor in a superﬁcial location or
a central tumor close proximity to a big vessel is more likely to
produce severe pain during the ablation procedure, however,
the level of pain is unpredictable [21–24].CA group (n= 40) ACA group (n= 40)
.3 (0.96) 4.42 (1.10)
(10) 5 (12.5)
9 (72.5) 28 (70)
(17.5) 7 (17.5)
8.77 ± 4.75 17.87 ± 4.70
analgesia, RFA: radiofrequency ablation. Data presented as
showed no statistical signiﬁcance (P> 0.05).
Table 3 Physiologic parameters, Pain score, patient-operator satisfaction.
PCA group (n= 40) ACA group (n= 40)
Physiologic parameters
Heart rate (beat/min) 83.5 ± 5.07 82 ± 5.66
Systolic blood pressure (mmHg) 134 ± 10.70 136 ± 9.60
Diastolic blood pressure (mmHg) 84.45 ± 4.20 85 ± 4.76
RR (breath/min) 13.37 ± 0.92 13.7 ± 1.06
Oxygen saturation (%) 99.1 ± 2.34 99.2 ± 2.11
Pain score (VAS) during RFA 3.37 ± 0.70* 3.97 ± 0.89*
Post operative Patient satisfaction (0–10) 8.32 ± 0.62* 7.85 ± 0.73*
Operator satisfaction (0–10) 8.25 ± 0.86 8.07 ± 0.76
PCA: patient-controlled analgesia; ACA: anesthesiologist-controlled analgesia, VAS: visual analog scale, RFA: radiofrequency ablation. Data
presented as mean ± standard deviation.
* Statistically signiﬁcant (P< 0.05).
Figure 2 Demand/delivery ratio in the studied groups.
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was signiﬁcantly higher in the PCA group (Table 3). Generally,
this could be attributed to the fact that the overall patient hap-
piness about the success of the procedure (successful destruc-
tion and killing of the tumors according to patient’s own
words), this concept encourage the patients to overcome the
discomfort encountered during the ablation process. Also pa-
tients tend to underestimate intra procedure pain since it was
inquired about after termination of the procedure not during
the ablation process. For that purpose, we monitored (de-
mand/delivered ratio) which is the ratio of analgesic requests
to successful deliveries. This ratio was signiﬁcantly higher in
the ACA group denoting large number of unsuccessful at-
tempts was indicative of inadequate pain relief although there
was post procedure high satisfaction rate. Another possible
reason for the higher satisfaction score in the PCA group is
that PCA may enhance patient’s satisfaction by giving them
a sense of control over an unpleasant stimulus [25]. Observa-
tional studies conﬁrm that patients experience high levels of
satisfaction when they have a degree of control over their
own analgesia and, if given the option, would preferentially
use patient controlled machines again [26].
Similar researches showed, that the risk factors related to
severity of pain during RFTA included larger tumors, multiple
ablations during the same session, and a increased in the dura-
tion of ablation. Larger hepatic tumors are usually treated
with multiple ablations, and also requiring longer durationof ablation [27]. In agreement with these ﬁndings, previous re-
ports described that multiple thermal ablations increase the
likelihood of complications [28,21]. Patients who did not expe-
rience RFTA procedure for tumors reported a higher VAS
during the procedure than patients with previous ablation.
This observation may be explained by the reduction of
unpleasantness for pain with training, even though the inten-
sity remains at an undiminished level [18]. Dissatisfaction or
emotional stress may be reduced in patients with recurrent le-
sions who have already experienced the RFTA procedure, as
the patient reports a lower VAS.
In conclusion, during radiofrequency thermal ablation,
PCA with fentanyl proved to be a better alternative than anes-
thesiologist – controlled technique in terms of patient comfort
and satisfaction. However, despite high satisfaction rates,
many patients still feel the need for more analgesia during
the procedure. Future multi-center trials comparing several
analgesic techniques during percutaneous radiofrequency ther-
mal ablation should be conducted to reﬁne analgesia needed
for such procedures.
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